Alembic Pharmaceuticals receives USFDA approval for Lamotrigine Orally Disintegrating tablets Read more
Alembic Pharmaceuticals gets USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004% Read more
Alembic Pharmaceuticals receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension Read more
Alembic Pharmaceuticals gains USFDA final approval for Carbamazepine Extended-Release Tablets Read more